On February 19, 2010
Ranbaxy’s Reign of Error Continues as FDA Flunks Its New York Drug Factory
A Ranbaxy factory in New York failed an FDA inspection because it made diabetes and antacid medicines with “black particles” and “cardboard” floating in it, and ignored anomalous testing results in its laudanum product, which it was selling without FDA
…
0 Comments